BridgeMD
New treatment option for Stuttering, Adult
Official title Using Transcranial Magnetic Stimulation to Treat Stuttering
ClinicalTrials.gov ID: NCT07389694
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if repeated transcranial magnetic stimuli (rTMS) can treat stuttering in adults. The main questions it aims to answer are: Will there be changes in the brains of people who stutter because of the treatment?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age from 18 to 65 years
- Self-identifies as a person who currently stutters
- Right-handed or left-handed
- Normal hearing and (corrected) vision
- Able to understand and give informed consent
You likely can't join if
- Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
- Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
- Facial tattoos
- Not having medical insurance
- Surgical clips in the head or previous neurosurgery
- Any magnetic particles in the body
See the full eligibility criteria
- Age from 18 to 65 years
- Self-identifies as a person who currently stutters
- Right-handed or left-handed
- Normal hearing and (corrected) vision
- Able to understand and give informed consent
- Monolingual English speaker
- Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
- Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
- Facial tattoos
- Not having medical insurance
- Surgical clips in the head or previous neurosurgery
- Any magnetic particles in the body
- Cochlear implants
- Prosthetic heart valves
- Epilepsy or any other type of seizure history
- History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
- Known structural brain lesions
- Pre-existing speech, language, or neurological disorder (except for stuttering)
- Significant other disease (heart disease, malignant tumors, mental disorders)
- Significant claustrophobia; Ménière's disease
- Women who are trying to get pregnant and sexually active women (of reproductive age) not on a reliable contraceptive
- Pregnancy, breastfeeding
- Medications increasing the risk for seizures
- Non-prescribed drug use
- Use of recreational drugs such as medical marijuana
- Failure to perform the behavioral tasks or neuropsychological evaluation tests
- Prisoners
The study team makes the final eligibility decision.
Where it's taking place
- Manhattan, Kansas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Manhattan, Kansas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.